Embarc

Leadership

Christopher Fuglesang, Ph.D.

SPACs
1
$125M
Biotech
BCTG
  1. Registration
  2. IPO
  3. Definitive Agreement
  4. Completed
Completed
BCTG Acquisition Corp.
Tango Therapeutics
TNGX25%